“BCL-2 TARGETED STRUCTURAL BASED COMPUTER AIDED DRUG DESIGN (CAAD) FOR THERAPEUTIC ASSESSMENT OF RICIN IN PROSTATE CANCER”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 7, no. 2, Sept. 2018, pp. 168-71, https://doi.org/10.25004/IJPSDR.2015.070207.